Thermo Fisher Scientific (TMO) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Thermo Fisher Scientific (TMO) last issued guidance on July 23, 2026 for fiscal year 2026. The company guided earnings per share in the range of $24.93 - $25.33, compared to a consensus EPS estimate of $24.85. Thermo Fisher Scientific also guided revenue in the range of $47.4B - $48.1B for the period.
Compared to prior guidance, Thermo Fisher Scientific raised its EPS outlook from a previous range of $24.64 - $25.12. On the revenue side, the company maintained its revenue forecast from a prior range of $47.3B - $48.1B.
Thermo Fisher Scientific has issued 17 guidance updates between October 26, 2022 and July 23, 2026. During this period, the company raised its outlook 6 times and lowered it 4 times, providing investors with insight into management's evolving expectations.
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $5.71 | $5.23 | $6.44 | $5.50 |
| Actual | $6.03 | $5.44 | $6.57 | $5.79 |
| Surprise | +5.60% | +4.02% | +2.02% | +5.27% |
| Revenue | ||||
| Estimate | $11.70B | $10.85B | $11.91B | $10.91B |
| Actual | $11.99B | $11.01B | $12.21B | $11.12B |
| Surprise | +2.54% | +1.38% | +2.54% | +1.92% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $6.40 | $7.28 | $5.93 | $6.55 |
| Revenue | ||||
| Consensus | $11.94B | $12.91B | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Jul 23, 2026 | $6.03 | $5.71 | 5.60 % |
| Q1 | Apr 23, 2026 | $5.44 | $5.23 | 4.02 % |
| Q4 | Jan 29, 2026 | $6.57 | $6.44 | 2.02 % |
| Q3 | Oct 22, 2025 | $5.79 | $5.50 | 5.27 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | Jul 23, 2026 | $11.99B | $11.70B | 2.54 % |
| Q1 | Apr 23, 2026 | $11.01B | $10.85B | 1.38 % |
| Q4 | Jan 29, 2026 | $12.22B | $11.91B | 2.54 % |
| Q3 | Oct 22, 2025 | $11.12B | $10.91B | 1.92 % |